SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-026004
Filing Date
2022-05-12
Accepted
2022-05-12 17:04:21
Documents
48
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0322_oramedpharma.htm   iXBRL 10-Q 453620
2 REPRESENTATIVE FORM OF INDEMNIFICATION AGREEMENTS BETWEEN ORAMED PHARMACEUTICALS f10q0322ex10-1_oramedpharma.htm EX-10.1 82994
3 CERTIFICATION f10q0322ex31-1_oramedpharma.htm EX-31.1 9756
4 CERTIFICATION f10q0322ex31-2_oramedpharma.htm EX-31.2 9753
5 CERTIFICATION f10q0322ex32-1_oramedpharma.htm EX-32.1 3342
6 CERTIFICATION f10q0322ex32-2_oramedpharma.htm EX-32.2 3052
  Complete submission text file 0001213900-22-026004.txt   3200384

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE ormp-20220331.xsd EX-101.SCH 40981
8 XBRL CALCULATION FILE ormp-20220331_cal.xml EX-101.CAL 27472
9 XBRL DEFINITION FILE ormp-20220331_def.xml EX-101.DEF 178165
10 XBRL LABEL FILE ormp-20220331_lab.xml EX-101.LAB 349447
11 XBRL PRESENTATION FILE ormp-20220331_pre.xml EX-101.PRE 182075
42 EXTRACTED XBRL INSTANCE DOCUMENT f10q0322_oramedpharma_htm.xml XML 274288
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35813 | Film No.: 22918840
SIC: 2834 Pharmaceutical Preparations